The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma

BACKGROUND: Neoadjuvant therapy followed by esophagectomy has been recognized as an effective treatment for locally advanced esophageal cancer, though still has a dismal prognosis. Antibodies against programmed death 1 (PD-1) protein improve survival in patients with advanced or metastatic esophagea...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Gastrointest Oncol
Main Authors: Shen, Dijian, Chen, Qixun, Wu, Jie, Li, Jianqiang, Tao, Kaiyi, Jiang, Youhua
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2021
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7944149/
https://ncbi.nlm.nih.gov/pubmed/33708420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-599
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki